Daniel K. Spiegelman, Director: Myriad Genetics MYGN Sell · Filed 24/06/04

Trade details

Type: Insider sale
Amount: $83,525.4
Shares · price: 3,788 sh · $22.05 a share
Held after: 32,917 sh
Stock: Myriad Genetics MYGN
Person: Daniel K. SpiegelmanDirector
Trade date: 24/06/04
Filed: 24/06/04
Days to filing: 0 days

Sold 10.3% of holdings

Share of holding sold: 10.3%

Myriad Genetics trades, last 26 weeks

What else happened in Myriad Genetics around then

Filed or reported within 30 days of the trade day · 24/05/05~24/07/04

Daniel K. Spiegelman's recent trades

Daniel K. SpiegelmanDirector
Planned saleKyverna Therapeutics
Planned sale
Kyverna Therapeutics
KYTX
$162.6K
17,578 sh
$162.6K
Filed 04/07
Traded 04/07
Daniel K. SpiegelmanDirector
Planned saleKyverna Therapeutics
Planned sale
Kyverna Therapeutics
KYTX
$140.4K
16,634 sh
$140.4K
Filed 03/31
Traded 03/31
Daniel K. SpiegelmanDirector
Sell10b5-1 planMyriad Genetics
Sell10b5-1 plan
Myriad Genetics
MYGN
$83.5K
3,788 sh
$83.5K
Filed 24/06/04
Traded 24/06/03
Daniel K. SpiegelmanDirector
SellMyriad Genetics
Sell
Myriad Genetics
MYGN
$198.8K
8,638 sh
$198.8K
Filed 23/06/02
Traded 23/06/02